Osteoporosis: New Treatments

Journal of the American Medical Directors Association

Volumn 16, Issue 4, 2015, Pages 265-267

  Morley, John E ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE DENSITY CONSERVATION AGENT;

FEMALE; HOME FOR THE AGED; HUMAN; MALE; NURSING HOME; OSTEOPOROSIS; OSTEOPOROTIC FRACTURES;

BONE DENSITY CONSERVATION AGENTS; FEMALE; HOMES FOR THE AGED; HUMANS; MALE; NURSING HOMES; OSTEOPOROSIS; OSTEOPOROTIC FRACTURES;

EID: 84934270669     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2015.02.001     Document Type: Editorial

References (99)

1. Zimmerman S.I., Girman C.J., Buie V.C., et al. The prevalence of osteoporosis in nursing home residents. Osteoporosis Int 1999, 9:151-157.
2. Chandler J.M., Zimmerman S.I., Girman C., et al. Low bone mineral density and risk of fracture in white female nursing home residents. JAMA 2000, 284:972-977.
3. Gloth F.M., Simonson W. Osteoporosis is underdiagnosed in skilled nursing facilities: A large-scale heel BMD screening study. JAm Med Dir Assoc 2008, 9:190-193.
4. Zarowitz B.J., Cheng L.I., Allen C., et al. Osteoporosis prevalence and characteristics of treated and untreated nursing home residents with osteoporosis. JAm Med Dir Assoc 2015, 16:341-348.
5. Shen S.H., Huang K.C., Tsai Y.H., et al. Risk analysis for second hip fracture in patients after hip fracture surgery: A nationwide population-based study. JAm Med Dir Assoc 2014, 15:725-731.
6. Toot S., Devine M., Akporobaro A., Orrell M. Causes of hospital admission for people with dementia: A systematic review and meta-analysis. JAm Med Dir Assoc 2013, 14:463-470.
7. Benzinger P., Becker C., Kerse N., et al. Pelvic fracture rates in community-living people with and without disability and in residents of nursing homes. JAm Med Dir Assoc 2013, 14:673-678.
8. Zimmerman S., Chandler J.M., Hawkes W., et al. Effect of fracture on the health care use of nursing home residents. Arch Intern Med 2002, 162:1502-1508.
9. Singer A., Spangler L., O'Malley C.D., et al. Hospitalization burden for osteoporotic fracture and other serious disease in older US women. Osteoporosis Int 2014, 25:S505.
10. Osnes E.K., Lofthus C.M., Meyer H.E., et al. Consequences of hip fracture on activities of daily life and residential needs. Osteoporos Int 2004, 15:567-574.
11. Morley J.E. Hip fractures. JAm Med Dir Assoc 2010, 11:81-83.
12. Martinez-Reig M., Ahmad L., Duque G. The orthogeriatric model of care: Systematic review of predictors of institutionalization and mortality in post-hip fracture patients and evidence for interventions. JAm Med Dir Assoc 2012, 13:770-777.
13. Curtis J.R., Arora T., Matthews R.S., et al. Is withholding osteoporosis medication after fracture sometimes rational? A comparison of the risk for second fracture versus death. JAm Med Dir Assoc 2010, 11:584-591.
14. Kennedy C.C., Thabane L., Ioannidis G., et al. Implementing a knowledge translation intervention in long-term care: Feasibility results from the Vitamin D and Osteoporosis Study (ViDOS). JAm Med Dir Assoc 2014, 15:943-945.
15. Morley J.E. Osteoporosis and fragility fractures. JAm Med Dir Assoc 2011, 12:389-392.
16. Duque G., Mallet L., Roberts A., et al. To treat or not to treat, that is the question: Proceedings of the Quebec symposium for the treatment of osteoporosis in long-term care institutions, Saint-Hyacinthe, Quebec, November 5, 2004. JAm Med Dir Assoc 2007, 8:e67-e73.
17. Janssen H.C., Emmelot-Vonk M.H., Verhaar H.J., van der Schouw Y.T. Vitamin D and muscle function: Is there a threshold in the relation?. JAm Med Dir Assoc 2013, 14:627.e13-627.e18.
18. Islam T., Peiris P., Copeland R.J., et al. Vitamin D: Lessons from the veterans population. JAm Med Dir Assoc 2011, 12:257-262.
19. Faulhaber G.A., Schulz L.F., Furlanetto T.W. Vitamin D status and ICU outcomes: Potential confounders. JAm Med Dir Assoc 2011, 12:e1-e2.
20. Demontiero O., Herrmann M., Duque G. Supplementation with vitamin D and calcium in long-term care residents. JAm Med Dir Assoc 2011, 12:190-194.
21. Hamid Z., Riggs A., Spencer T., et al. Vitamin D deficiency in residents of academic long-term care facilities despite having been prescribed vitamin D. JAm Med Dir Assoc 2007, 8:71-75.
22. Morley J.E. Vitamin D redux. JAm Med Dir Assoc 2009, 10:591-592.
23. Morley J.E. Should all long-term care residents receive vitamin D?. JAm Med Dir Assoc 2007, 8:69-70.
24. Michaëlsson K., Melhus H., Warensjö Lemming E., et al. Long term calcium intake and rates of all cause and cardiovascular mortality: Community based prospective longitudinal cohort study. BMJ 2013, 346:f228.
25. Reid I.R., Bristow S.M., Bolland M.J. Cardiovascular complications of calcium supplements. JCell Biochem 2015, 116:494-501.
26. Cao L., Chen S., Zou C., et al. Apilot study of the SARC-F scale on screening sarcopenia and physical disability in the Chinese older people. JNutr Health Aging 2014, 18:277-283.
27. Morley J.E. Sarcopenia: Diagnosis and treatment. JNutr Health Aging 2008, 12:452-456.
28. Rossi A.P., Fantin F., Micciolo R., et al. Identifying sarcopenia in acute care setting patients. JAm Med Dir Assoc 2014, 15:303.e7-303.e12.
29. Chen L.K., Liu L.K., Woo J., et al. Sarcopenia in Asia: Consensus report of the Asian Working Group for Sarcopenia. JAm Med Dir Assoc 2014, 15:95-101.
30. Yamada M., Nishiguchi S., Fukutani N., et al. Prevalence of sarcopenia in community-dwelling Japanese older adults. JAm Med Dir Assoc 2013, 14:911-915.
31. Woo J., Leung J., Morley J.E. Defining sarcopenia in terms of incident adverse outcomes. JAm Med Dir Assoc 2015, 16:247-252.
32. Kim H., Suzuki T., Kim M., et al. Incidence and predictors of sarcopenia onset in community-dwelling elderly Japanese women: 4-year follow-up study. JAm Med Dir Assoc 2015, 16:85.e1-85.e8.
33. Landi F., Martone A.M., Calvani R., Marzetti E. Sarcopenia risk screening tool: A new strategy for clinical practice. JAm Med Dir Assoc 2014, 15:613-614.
34. Lee W.J., Liu L.K., Peng L.N., et al. Comparisons of sarcopenia defined by IWGS and EWGSOP criteria among older people: Results from the I-Lan longitudinal aging study. JAm Med Dir Assoc 2013, 14:528.e1-528.e7. ILAS Research Group.
35. Coin A., Sarti S., Ruggiero E., et al. Prevalence of sarcopenia based on different diagnostic criteria using DEXAS and appendicular skeletal muscle mass reference values in an Italian population aged 20 to 80. JAm Med Dir Assoc 2013, 14:507-512.
36. Roman D., Mahoney K., Mohamadi A. Sarcopenia: What's in a name?. JAm Med Dir Assoc 2013, 14:80-82.
37. Buchele G., Becker C., Cameron I.D., et al. Predictors of serious consequences of falls in residential aged care: Analysis of more than 70,000 falls from residents of Bavarian nursing homes. JAm Med Dir Assoc 2014, 15:559-563.
38. Morley J.E. Falls and fractures. JAm Med Dir Assoc 2007, 8:276-278.
39. Morley J.E. Frailty, falls, and fractures. JAm Med Dir Assoc 2013, 14:149-151.
40. Silva R.B., Eslick G.D., Duque G. Exercise for falls and fracture prevention in long term care facilities: A systematic review and meta-analysis. JAm Med Dir Assoc 2013, 14:685-689.e2.
41. Rochat S., Monod S., Seematter-Bagnoud L., et al. Fallers in postacute rehabilitation have worse functional recovery and increased health services use. JAm Med Dir Assoc 2013, 14:832-836.
42. Kurita N., Horie S., Yamazaki S., et al. Low testosterone levels, depressive symptoms, and falls in older men: A cross-sectional study. JAm Med Dir Assoc 2014, 15:30-35.
43. Ogama N., Sakurai T., Shimizu A., Toba K. Regional white matter lesions predict falls in patients with amnestic mild cognitive impairment and Alzheimer's disease. JAm Med Dir Assoc 2014, 15:36-41.
44. Morley J.E., Rolland Y., Tolson D., Velals B. Increasing awareness of the factors producing falls: The mini falls assessment. JAm Med Dir Assoc 2012, 13:87-90.
45. Landi F., Onder G., Bernabei R. Sarcopenia and diabetes: Two sides of the same coin. JAm Med Dir Assoc 2013, 14:540-541.
46. Gryson C., Ratel S., Rance M., et al. Four-month course of soluble milk proteins interacts with exercise to improve muscle strength and delay fatigue in elderly participants. JAm Med Dir Assoc 2014, 15:958.e1-958.e9.
47. Valenzuela T. Efficacy of progressive resistance training interventions in older adults in nursing homes: A systematic review. JAm Med Dir Assoc 2012, 13:418-428.
48. Tieland M., Dirks M.L., van der Zwaluw N., et al. Protein supplementation increases muscle mass gain during prolonged resistance-type exercise training in frail elderly people: A randomized, double-blind, placebo-controlled trial. JAm Med Dir Assoc 2012, 13:713-719.
49. Paddon-Jones D. Perspective: Exercise and protein supplementation in frail elders. JAm Med Dir Assoc 2013, 14:73-74.
50. Brienesse L.A., Emerson M.N. Effects of resistance training for people with Parkinson's disease: A systematic review. JAm Med Dir Assoc 2013, 14:236-241.
51. Cadore E.L., Izquierdo M. New strategies for the concurrent strength-, power-, and endurance-training prescription in elderly individuals. JAm Med Dir Assoc 2013, 14:623-624.
52. Singh N.A., Quine S., Clemson L.M., et al. Effects of high-intensity progressive resistance training and targeted multidisciplinary treatment of frailty on mortality and nursing home admissions after hip fracture: A randomized controlled trial. JAm Med Dir Assoc 2012, 13:24-30.
53. Morse A., McDonald M.M., Kelly N.H., et al. Mechanical load increases in bone formation via a sclerostin-independent pathway. JBone Miner Res 2014, 29:2456-2467.
54. Huo Y.R., Suriyaarachchi P., Gomez F., et al. Phenotype of osteosarcopenia inolder individuals with a history of falling. JAm Med Dir Assoc 2015, 16:290-295.
55. Yu R., Leung J., Woo J. Incremental predictive value of sarcopenia for incident fracture in an elderly Chinese cohort: Results from the Osteoporotic Fractures in Men (MrOs) Study. JAm Med Dir Assoc 2014, 15:551-558.
56. Yu R., Leung J., Woo J. Sarcopenia combined with FRAX probabilities improves fracture risk prediction in older Chinese men. JAm Med Dir Assoc 2014, 15:918-923.
57. Cederholm T., Morley J.E. Sarcopenia: The new definitions. Curr Opin Clin Nutr Metab Care 2015, 18:1-4.
58. Formiga F., Ferrer A., Padros G., et al. Diabetes mellitus as a risk factor for functional and cognitive decline in very old people: The Octabaix study. JAm Med Dir Assoc 2014, 15:924-928.
59. Hita-Contreras F., Martinez-Amat A., Cruz-Diaz D., Perez-Lopez F.R. Osteosarcopenia obesity and fall prevention strategies. Maturitas 2015, 80:126-132.
60. Tamura B.K., Bell C.L., Masaki K.H., Amella E.J. Factors associated with weight loss, low BMI, and malnutrition among nursing home patients: A systematic review of the literature. JAm Med Dir Assoc 2013, 14:649-655.
61. Soenen S., Chapman I.M. Body weight, anorexia, and undernutrition in older people. JAm Med Dir Assoc 2013, 14:642-648.
62. Morley J.E. Weight loss in older persons: New therapeutic approaches. Curr Pharm Des 2007, 13:3637-3647.
63. Morley J.E. Anorexia of aging: A true geriatric syndrome. JNutr Health Aging 2012, 16:422-425.
64. Argiles J.M., Anker S.D., Evans W.J., et al. Consensus on cachexia definitions. JAm Med Dir Assoc 2010, 11:229-230.
65. Von Haehling S., Morley J.E., Anker S.D. From muscle wasting to sarcopenia and myopenia: Update 2012. JCachexia Sarcopenia Muscle 2012, 3:213-217.
66. Morley J.E., von Haehling S., Anker S.D., Vellas B. From sarcopenia to frailty: A road less traveled. JCachexia Sarcopenia Muscle 2014, 5:5-8.
67. Morley J.E. Pathophysiology of the anorexia of aging. Curr Opin Clin Nutr Metab Care 2013, 16:27-32.
68. Bell C.L., Tamura B.K., Masaki K.H., Amella E.J. Prevalence and measures of nutritional compromise among nursing home patients: Weight loss, low body mass index, malnutrition, and feeding dependency, a systematic review of the literature. JAm Med Dir Assoc 2013, 14:94-100.
69. Morley J.E. Undernutrition: A major problem in nursing homes. JAm Med Dir Assoc 2011, 12:243-246.
70. Woo J., Leung J., Morley J.E. Validating the SARC-F: A suitable community screening tool for sarcopenia?. JAm Med Dir Assoc 2014, 15:630-634.
71. Chen F., Hahn T.J., Weintraub N.T. Do SSRIs play a role in decreasing bone mineral density?. JAm Med Dir Assoc 2012, 13:413-417.
72. Iraqi A., Baickle E. Acase report of hyponatremia with citalopram use. JAm Med Dir Assoc 2004, 5:64-65.
73. Morley J.E. Depression in nursing home residents. JAm Med Dir Assoc 2010, 11:301-303.
74. Grey A. Diabetes medications and bone. Curr Osteoporos Rep 2015, 13:35-40.
75. Zhu Z.N., Jiang Y.F., Ding T. Risk of fracture with thiazolidinediones: An updated meta-analysis of randomized clinical trials. Bone 2014, 68:115-123.
76. Leontiadis G.I., Moayyedi P. Proton pump inhibitors and risk of bone fractures. Curr Treat Options Gastroenterol 2014, 12:414-423.
77. Jamal S.A., Arampatzis S., Harrison S.L., et al. Hyponatremia and fractures: Findings from the Osteoporotic Fractures in Men study. JBone Miner Res 2014 Oct 7, [Epub ahead of print].
78. Cumming K., Hoyle G.E., Hutchison J.D., Soiza R.L. Prevalence, incidence and etiology of hyponatremia in elderly patients with fragility fractures. PLoS One 2014, 9:e88272.
79. Uriz-Otano F., Uriz-Otano J.I., Malafarina V. Factors associated with short-term functional recovery in elderly people with a hip fracture. Influence of cognitive impairment. JAm Med Dir Assoc 2015, 16:215-220.
80. Rudolph J.L., Archambault E., Kelly B. VA Boston Delirium Task Force. A delirium risk modification program is associated with hospital outcomes. JAm Med Dir Assoc 2014, 15:957.e7-957.e11.
81. Flaherty J.H., Morley J.E. Delirium in the nursing home. JAm Med Dir Assoc 2008, 9:157-161.
82. Eeles E., Rockwood K. Delirium in the long-term care setting: Clinical and research challenges. JAm Med Dir Assoc 2008, 9:157-161.
83. Rockwood K. Making delirium prevention acceptable in nursing homes. JAm Med Dir Assoc 2014, 15:6-7.
84. Leenders M., Verdijk L.B., van der Hoeven L., et al. Patients with type 2 diabetes show a greater decline in muscle mass, muscle strength, and functional capacity with aging. JAm Med Dir Assoc 2013, 14:585-592.
85. Morley J.E., Malmstrom T.K., Rodriguez-Manas L., Sinclair A.J. Frailty, sarcopenia and diabetes. JAm Med Dir Assoc 2014, 15:853-859.
86. Sinclair A., Morley J.E., Rodriguez-Manas L., et al. Diabetes mellitus in older people: Position statement on behalf of the International Association of Gerontology and Geriatrics (IAGG), the European Diabetes Working Party for Older People (EDWPOP), and the International Task Force on Experts in Diabetes. JAm Med Dir Assoc 2012, 13:497-502.
87. Mallery L.H., Ransom T., Steeves B., et al. Evidence-informed guidelines for treating frail older adults with type 2 diabetes: From the Diabetes Care Program of Nova Scotia (DCPNS) and the Palliative Therapeutic Harmonization (PATH) program. JAm Med Dir Assoc 2013, 14:801-808.
88. Bernabei R., Martone A.M., Ortolani E., et al. Screening, diagnosis and treatment of osteoporosis: A brief review. Clin Cases Miner Bone Metab 2014, 11:201-207.
89. Narayanan P. Denosumab: A comprehensive review. South Asian J Cancer 2013, 2:272-277.
90. Cianferotti L., D'Asta F., Brandi M.L. Areview on strontium ranelate long-term antifracture efficacy in the treatment of postmenopausal osteoporosis. Ther Adv Musculoskelet Dis 2013, 5:127-139.
91. Reginster J.Y. Cardiac concerns associated with strontium ranelate. Expert Opin Drug Saf 2014, 13:1209-1213.
92. Crandall C.J., Newberry S.J., Diamant A., et al. Comparative effectiveness of pharmacologic treatments to prevent fractures: An updated systematic review. Ann Intern Med 2014, 161:711-723.
93. Yavropoulou M.P., Xygonakis C., Lolou M., et al. The sclerostin story: From human genetics to the development of novel anabolic treatment for osteoporosis. Hormones (Athens) 2014, 13:323-337.
94. Bone H.G., Dempster D.W., Eisman J.A., et al. Odanacatib for the treatment of postmenopausal osteoporosis: Development history and design and participant characteristics of LOFT, the long-term odanacatib fracture trial. Osteoporos Int 2015, 26:699-712.
95. Amory J.K., Watts N.B., Easley K.A., et al. Exogenous testosterone or testosterone with finasteride increases bone mineral density in older men with low serum testosterone. JClin Endocrinol Metab 2004, 89:503-510.
96. Morley J.E. Scientific overview of hormone treatment used for rejuvenation. Fertil Steril 2013, 99:1807-1813.
97. Morley J.E. Hypogonadism, testosterone, and nursing home residents. JAm Med Dir Assoc 2013, 14:381-383.
98. Morley J.E., Caplan G., Cesari M., et al. International survey of nursing home resident priorities. JAm Med Dir Assoc 2014, 15:309-312.
99. Tolson D., Rolland Y., Andrieu S., et al. International Association of Gerontology and Geriatrics: A global agenda for clinical research and quality of care in nursing homes. JAm Med Dir Assoc 2011, 12:184-189.